Bradmer Pharmaceuticals (TSE:GLX) Upgraded at Cantor Fitzgerald
Cantor Fitzgerald upgraded shares of Bradmer Pharmaceuticals (TSE:GLX – Free Report) to a strong-buy rating in a report published on Tuesday,Zacks.com reports. Cantor Fitzgerald also issued estimates for Bradmer Pharmaceuticals’ FY2024 earnings at $2.74 EPS and FY2025 earnings at $3.35 EPS. Bradmer Pharmaceuticals Price Performance Recommended Stories Five stocks we like better than Bradmer Pharmaceuticals […]
Cantor Fitzgerald upgraded shares of Bradmer Pharmaceuticals (TSE:GLX – Free Report) to a strong-buy rating in a report published on Tuesday,Zacks.com reports. Cantor Fitzgerald also issued estimates for Bradmer Pharmaceuticals’ FY2024 earnings at $2.74 EPS and FY2025 earnings at $3.35 EPS. Bradmer Pharmaceuticals Price Performance Recommended Stories Five stocks we like better than Bradmer Pharmaceuticals […]
